Mutational analysis of stem-loops in the RNA packaging signal of the moloney murine leukemia virus

Virology

Volumn 244, Issue 1, 1998, Pages 133-145

  Fisher, John ^a   Goff, Stephen P ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ARTICLE; BASE PAIRING; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; RNA STRUCTURE; VIRION; VIRUS MUTANT; VIRUS REPLICATION;

ANIMALIA; DNA VIRUSES; MOLONEY MURINE LEUKEMIA VIRUS; MURINAE; ONCOVIRINAE; RNA VIRUSES;

EID: 0032565360     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9090     Document Type: Article

References (38)

1. Adam M. A., Miller A. D. Identification of a signal in a murine retrovirus that is sufficient for packaging of nonretroviral RNA into virions. J. Virol. 62:1988;3802-3806.
2. Alford R. L., Honda S., Lawrence C. B., Belmont J. W. RNA secondary structure analysis of the packaging signal for Moloney murine leukemia virus. Virology. 183:1991;611-619.
3. Armentano D., Yu S., Kantoff P. W., von Ruden T., Anderson W. F., Gilboa E. Effect of internal viral sequences on the utility of retroviral vectors. J. Virol. 61:1987;1647-1650.
4. Bender M. A., Palmer T. D., Gelinas R. E., Miller A. D. Evidence that the packaging signal of Moloney murine leukemia virus extends into thegagregion. J. Virol. 61:1987;1639-1646.
5. Bender W., Davidson N. Mapping of poly(A) sequences in the electron microscope reveals unusual structure of type C oncornavirus RNA molecules. Cell. 7:1976;595-607.
6. Berkowitz R. D., Fisher J., Goff S. P. RNA packaging. Curr. Top. Microbiol. 214:1996;177-218.
7. Berkowitz R. D., Luban J., Goff S. P. Specific binding of human immunodeficiency virus type 1gagpolyprotein and nucleocapsid protein to viral RNAs detected by RNA mobility shift assays. J. Virol. 67:1993;7190-7200.
8. Berlioz C., Darlix J. L. An internal ribosomal entry mechanism promotes translation of murine leukemia virus gag polyprotein precursors. J. Virol. 69:1995;2214-2222.
9. Bieth E., Gabus C., Darlix J.-L. A study of the dimer formation of Rous sarcoma virus RNA and of its effect on viral protein synthesisin vitro. Nucleic Acids Res. 18:1990;119-127.
10. Blain S. W., Hendrickson W. A., Goff S. P. Reversion of a Moloney murine leukemia virus RNase H mutant at a second site restores enzyme function and infectivity. J. Virol. 69:1995;5113-5116.
11. Campbell S., Vogt V. M. Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J. Virol. 69:1995;6487-6497.
12. Carey J., Cameron V., Haseth P. d., Uhlenbeck O. C. Sequence-specific interaction of R17 coat protein witits ribonucleic acid binding site. Biochemistry. 22:1983;2601-2610.
13. Colicelli J., Goff S. P. Mutants and pseudorevertants of Moloney murine leukemia virus with alterations at the integration site. Cell. 42:1985;573-580.
14. Colicelli J., Goff S. P. Isolation of a recombinant murine leukemia virus utilizing a new primer tRNA. J. Virol. 57:1987;37-45.
15. Fu W., Rein A. Maturation of dimeric viral RNA of Moloney murine leukemia virus. J. Virol. 67:1993;5443-5449.
16. Goff S. P., Traktman P., Baltimore D. Isolation and properties of Moloney murine leukemia virus mutants: Use of a rapid assay for release of virion reverse transcriptase. J. Virol. 38:1981;239-248.
17. Katoh I., Yasunaga T., Yoshinaka Y. Bovine leukemia virus RNA sequences involved in dimerization and specific gag protein binding: Close relation to the packaging sites of avian, murine, and human retroviruses. J. Virol. 67:1993;1830-1839.
18. Katz R. A., Terry R. W., Skalka A. M. A conserved cis-acting sequence in the 5′ leader of avian sarcoma virus RNA is required for packaging. J. Virol. 59:1986;163-167.
19. Konings D. A., Nash M. A., Maizel J. V., Arlinghaus R. B. Novel GACG-hairpin pair motif in the 5′ untranslated region of type C retroviruses related to murine leukemia virus. J. Virol. 66:1992;632-640.
20. Lever A., Gottlinger H., Haseltine W., Sodroski J. Identification of a sequence required for efficient packaging of human immunodeficiency virus type 1 RNA into virions. J. Virol. 63:1989;4085-4087.
21. Linial M., Miller A. D. Retroviral RNA packaging: Sequence requirements and implications. Curr. Top. Microbiol. Immunol. 157:1990;125-152.
22. Mann R., Baltimore D. Varying the position of a retrovirus packaging sequence results in the encapsidation of both unspliced and spliced RNAs. J. Virol. 54:1985;401-407.
23. Mann R., Mulligan R. C., Baltimore D. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell. 33:1983;153-159.
24. Mougel M., Tounekti N., Darlix J.-L., Paoletti J., Ehresmann B., Ehresmann C. Conformational analysis of the 5′ leader and thegaginitiation site of Mo-MuLV RNA and allosteric transitions induced by dimerization. Nucleic Acids Res. 21:1993;4677-4684.
25. Mougel M., Zhang Y., Barklis E. cis-Active structural motifs involved in specific encapsidation of Moloney murine leukemia virus RNA. J. Virol. 70:1996;5043-5050.
26. Murphy J. E., Goff S. P. Construction and analysis of deletion mutations in the U5 region of Moloney murine leukemia virus: Effects on RNA packaging and reverse transcription. J. Virol. 63:1989;319-327.
27. Prats A., Roy C., Wang P., Erard M., Housset V., Gabus C., Paoletti C., Darlix J.-L. Cis elements and trans-acting factors involved in dimer formation of murine leukemia virus RNA. J. Virol. 64:1990;774-783.
28. Pugatsch T., Stacey D. W. Identification of a sequence likely to be required for avian retroviral packaging. Virology. 128:1983;505-511.
29. Romaniuk P. J., Lowary P., Wu H. N., Stormo G., Ulenbeck O. C. RNA binding site of R17 coat protein. Biochemistry. 26:1987;1563-1568.
30. Sakalian M., Parker S. D., Weldon R. A. J., Hunter E. Synthesis and assembly of retrovirus Gag precursors into immature capsids in vitro. J. Virol. 70:1996;3706-3715.
31. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
32. Schneider D., Tuerk C., Gold L. Selection of high affinity RNA ligands to the bacteriophage R17 coat protein. J. Mol. Biol. 228:1992;862-869.
33. Schwartzberg P., Colicelli J., Goff S. P. Deletion mutants of Moloney murine leukemia virus which lack glycosylatedgagprotein are replication competent. J. Virol. 46:1983;538-546.
34. Schwartzberg P., Colicelli J., Goff S. P. Recombination between a defective retrovirus and homologous sequences in host DNA: Reversion by patch repair. J. Virol. 53:1985;719-726.
35. Tanese N., Telesnitsky A., Goff S. P. Abortive reverse transcription by mutants of Moloney murine leukemia virus deficient in reverse transcriptase-associated RNAse H function. J. Virol. 65:1991;4387-4397.
36. Tounekti N., Mougel M., Roy C., Marquet R., Darlix J.-L., Paoletti J., Ehresmann B., Ehresmann C. Effect of dimerization on the conformation of the encapsidation Psi domain of Moloney murine leukemia virus RNA. J. Mol. Biol. 223:1992;205-220.
37. Watanabe S., Temin H. M. Encapsidation sequences for spleen necrosis virus, an avian retrovirus, are between the 5′ long terminal repeat and the start of thegaggene. Proc. Natl. Acad. Sci. USA. 79:1982;5986-5990.
38. Yang S., Temin H. M. A double hairpin structure is necessary for the efficient encapsidation of spleen necrosis virus retroviral RNA. EMBO J. 13:1994;713-726.